TABLE 1.
Organism and agent (no. of isolates) | MIC (μg/ml)s
|
Organism and agent (no. of isolates) | MIC (μg/ml)s
|
|||||
---|---|---|---|---|---|---|---|---|
Range | 50% | 90% | Range | 50% | 90% | |||
Bergeyella zoohelcum (11) | ||||||||
BMS-284756 | ≤0.015-≤0.015 | ≤0.015 | ≤0.015 | |||||
Moxifloxacin | ≤0.015-≤0.015 | ≤0.015 | ≤0.015 | |||||
Levofloxacin | 0.06-0.125 | 0.06 | 0.06 | |||||
Ciprofloxacin | 0.03-0.125 | 0.06 | 0.06 | |||||
Amoxicillin-clavulanate | ≤0.06-0.25 | ≤0.06 | 0.125 | |||||
Cefotetan | ≤0.06-8 | 2 | 8 | |||||
Penicillin G | ≤0.06-0.25 | ≤0.06 | 0.125 | |||||
Ampicillin-sulbactam | ≤0.06-0.25 | ≤0.06 | 0.125 | |||||
Doxycycline | 0.25-2 | 2 | 2 | |||||
Corynebacterium spp. (19)a | ||||||||
BMS-284756 | ≤0.015-8 | 0.25 | 1 | |||||
Moxifloxacin | ≤0.015-2 | 0.25 | 0.5 | |||||
Levofloxacin | 0.06-8 | 2 | 8 | |||||
Ciprofloxacin | ≤0.015->8 | 2 | 4 | |||||
Amoxicillin-clavulanate | ≤0.06-2 | 1 | 2 | |||||
Cefotetan | ≤0.06->32 | 32 | >32 | |||||
Penicillin G | ≤0.06-2 | 1 | 2 | |||||
Ampicillin-sulbactam | ≤0.06-2 | 1 | 2 | |||||
Doxycycline | 0.05-1 | 0.25 | 0.25 | |||||
CDC groups EF-4a and EF-4b (15)b | ||||||||
BMS-284756 | ≤0.015-0.125 | ≤0.015 | 0.06 | |||||
Moxifloxacin | ≤0.015-0.125 | ≤0.015 | 0.06 | |||||
Levofloxacin | ≤0.015-0.06 | ≤0.015 | 0.06 | |||||
Ciprofloxacin | ≤0.015-0.06 | ≤0.015 | 0.03 | |||||
Amoxicillin-clavulanate | ≤0.06-0.5 | 0.25 | 0.5 | |||||
Cefotetan | 0.125-4 | 0.5 | 1 | |||||
Penicillin G | ≤0.06-0.5 | 0.25 | 0.5 | |||||
Ampicillin-sulbactam | ≤0.06-0.5 | 0.25 | 0.5 | |||||
Doxycycline | 0.125-0.25 | 0.25 | 0.25 | |||||
Eikenella corrodens (16) | ||||||||
BMS-284756 | ≤0.015-0.125 | 0.03 | 0.06 | |||||
Moxifloxacin | ≤0.015-0.03 | ≤0.015 | 0.03 | |||||
Levofloxacin | ≤0.015-≤0.015 | ≤0.015 | ≤0.015 | |||||
Ciprofloxacin | ≤0.015-≤0.015 | ≤0.015 | ≤0.015 | |||||
Amoxicillin-clavulanate | ≤0.06-0.5 | 0.25 | 0.5 | |||||
Cefotetan | 0.125-1 | 0.5 | 1 | |||||
Penicillin G | 0.125-0.5 | 0.5 | 0.5 | |||||
Ampicillin-sulbactam | 0.125-0.5 | 0.5 | 0.6 | |||||
Doxycycline | 2-16 | 4 | 8 | |||||
Enterococcus spp. (14)c | ||||||||
BMS-284756 | ≤0.015-0.25 | 0.03 | 0.25 | |||||
Moxifloxacin | 0.03-0.25 | 0.06 | 0.25 | |||||
Levofloxacin | 0.06-1 | 0.5 | 1 | |||||
Ciprofloxacin | 0.06-1 | 0.5 | 1 | |||||
Amoxicillin-clavulanate | ≤0.06-1 | ≤0.06 | 1 | |||||
Cefotetan | 0.125->32 | 16 | >32 | |||||
Penicillin G | ≤0.06-1 | ≤0.06 | 1 | |||||
Ampicillin-sulbactam | ≤0.06-1 | ≤0.06 | 1 | |||||
Doxycycline | ≤0.06-16 | 0.125 | 16 | |||||
Fastidious gram-negative bacilli (16)d | ||||||||
BMS-284756 | ≤0.015-1 | ≤0.015 | 0.125 | |||||
Moxifloxacin | ≤0.015-4 | 0.06 | 0.5 | |||||
Levofloxacin | ≤0.015->8 | 0.03 | 1 | |||||
Ciprofloxacin | ≤0.015-8 | 0.03 | 2 | |||||
Amoxicillin-clavulanate | ≤0.06-4 | 0.25 | 1 | |||||
Cefotetan | ≤0.06->32 | 1 | >32 | |||||
Penicillin G | ≤0.06-4 | 0.25 | 0.5 | |||||
Ampicillin-sulbactam | ≤0.06-4 | 0.25 | 0.5 | |||||
Doxycycline | 0.125-4 | 1 | 4 | |||||
Moraxella spp. (21)e | ||||||||
BMS-284756 | ≤0.015-0.06 | ≤0.015 | 0.03 | |||||
Moxifloxacin | ≤0.015-0.06 | ≤0.015 | 0.06 | |||||
Levofloxacin | ≤0.015-0.06 | ≤0.015 | 0.06 | |||||
Ciprofloxacin | ≤0.015-0.06 | ≤0.015 | 0.06 | |||||
Amoxicillin-clavulanate | ≤0.06-0.5 | ≤0.06 | 0.5 | |||||
Cefotetan | ≤0.06-1 | 0.125 | 0.5{tt}/PICK>{tt} | |||||
Staphylococcus spp. (19)h | ||||||||
BMS-284756 | ≤0.015-0.125 | ≤0.015 | 0.06 | |||||
Moxifloxacin | ≤0.015-0.5 | 0.06 | 0.125 | |||||
Levofloxacin | ≤0.015-2 | 0.125 | 0.25 | |||||
Ciprofloxacin | ≤0.015-2 | 0.125 | 0.25 | |||||
Amoxicillin-clavulanate | ≤0.06-0.5 | 0.125 | 0.25 | |||||
Cefotetan | ≤0.06-32 | 8 | 16 | |||||
Penicillin G | ≤0.06-1 | ≤0.06 | 0.5 | |||||
Ampicillin-sulbactam | ≤0.06-1 | ≤0.06 | 0.5 | |||||
Doxycycline | ≤0.06-8 | ≤0.06 | 4 | |||||
“Streptococcus milleri” group (19)i | ||||||||
BMS-284756 | 0.03-0.5 | 0.06 | 0.125 | |||||
Moxifloxacin | 0.06-2 | 0.25 | 0.25 | |||||
Levofloxacin | 0.5-8 | 1 | 2 | |||||
Ciprofloxacin | 0.5-8 | 1 | 4 | |||||
Amoxicillin-clavulanate | ≤0.06-0.5 | ≤0.06 | 0.25 | |||||
Cefotetan | 1-16 | 4 | 16 | |||||
Penicillin G | ≤0.06-0.5 | 0.125 | 0.5 | |||||
Ampicillin-sulbactam | ≤0.06-0.5 | 0.125 | 0.5 | |||||
Doxycycline | ≤0.06->32 | 1 | >32 | |||||
Bacteroides tectus (10) | ||||||||
BMS-284756 | ≤0.015-0.125 | 0.03 | 0.06 | |||||
Moxifloxacin | 0.06-0.125 | 0.06 | 0.125 | |||||
Levofloxacin | 0.125-0.5 | 0.25 | 0.25 | |||||
Ciprofloxacin | 0.5-2 | 0.5 | 1 | |||||
Amoxicillin-clavulanate | ≤0.06-0.5 | ≤0.06 | 0.125 | |||||
Cefotetan | 0.25-8 | 0.5 | 0.5 | |||||
Penicillin G | 0.03-32 | 0.03 | 0.125 | |||||
Ampicillin-sulbactam | ≤0.06-1 | ≤0.06 | 0.25 | |||||
Doxycycline | 0.125-8 | 0.25 | 0.5 | |||||
Bacteroides ureolyticus group (13)j | ||||||||
BMS-284756 | ≤0.015-2 | ≤0.015 | 1 | |||||
Moxifloxacin | ≤0.015->8 | 0.125 | >8 | |||||
Levofloxacin | ≤0.015->8 | 0.125 | >8 | |||||
Ciprofloxacin | ≤0.015->8 | 0.06 | >8 | |||||
Amoxicillin-clavulanate | ≤0.06->32 | 0.25 | >32 | |||||
Cefotetan | 0.125->32 | 1 | >32 | |||||
Penicillin G | ≤0.015->32 | 0.25 | >32 | |||||
Ampicillin-sulbactam | ≤0.06->32 | 0.25 | >32 | |||||
Doxycycline | 0.125-2 | 0.25 | 2 | |||||
Eubacterium spp. (13)k | ||||||||
BMS-284756 | 0.03-0.5 | 0.06 | 0.25 | |||||
Moxifloxacin | 0.125-1 | 0.125 | 0.5 | |||||
Levofloxacin | 0.125-2 | 0.25 | 2 | |||||
Ciprofloxacin | 0.25-4 | 0.5 | 2 | |||||
Amoxicillin-clavulanate | ≤0.06-0.25 | ≤0.06 | 0.25 | |||||
Cefotetan | 0.25-8 | 0.5 | 4 | |||||
Penicillin G | ≤0.015-0.5 | 0.06 | 0.25 | |||||
Ampicillin-sulbactam | ≤0.06-0.25 | ≤0.06 | 0.125 | |||||
Doxycycline | ≤0.06-2 | 0.5 | 2 | |||||
Fusobacterium russii (9) | ||||||||
BMS-284756 | 4->8 | 8 | NA | |||||
Moxifloxacin | 4-8 | 8 | NA | |||||
Levofloxacin | >8->8 | >8 | NA | |||||
Ciprofloxacin | >8->8 | >8 | NA | |||||
Amoxicillin-clavulaNAte | ≤0.06-0.125 | ≤0.06 | NA | |||||
Cefotetan | ≤0.06-0.25 | ≤0.06 | NA | |||||
Penicillin G | ≤0.015->32 | 0.03 | NA | |||||
Ampicillin-sulbactam | ≤0.06-2 | ≤0.06 | NA | |||||
Doxycycline | ≤0.06-0.25 | ≤0.06 | NA | |||||
Fusobacterium spp., animal isolates (12)l | ||||||||
BMS-284756 | 0.125->8 | 1 | >8 | |||||
Moxifloxacin | 0.25->8 | 1 | >8 | |||||
Levofloxacin | 0.25->8 | 1 | >8 | |||||
Ciprofloxacin | 0.125->8 | 4 | >8{tt} | |||||
Amoxicillin-clavulanate | ≤0.06-≤0.06 | ≤0.06 | ≤0.06 | |||||
Cefotetan | ≤0.06-0.25 | ≤0.06 | 0.25 | |||||
Penicillin G | ≤0.015-0.25 | ≤0.015 | 0.5 | |||||
Ampicillin-sulbactam | ≤0.06-0.125 | ≤0.06 | ≤0.06 | |||||
Doxycycline | 0.125-0.5 | 0.125 | 0.25 | |||||
Fusobacterium spp., human isolates (14)m | ||||||||
BMS-284756 | ≤0.015-0.5 | 0.25 | 0.5 | |||||
Moxifloxacin | 0.125-0.25 | 0.125 | 0.25 | |||||
Levofloxacin | 0.125-1 | 0.25 | 1 | |||||
Ciprofloxacin | 0.25-4 | 2 | 4 | |||||
Amoxicillin-clavulanate | ≤0.06-0.125 | ≤0.06 | ≤0.06 | |||||
Cefotetan | ≤0.06-1 | ≤0.06 | 0.5 | |||||
Penicillin G | ≤0.015-0.06 | ≤0.015 | 0.06 | |||||
Ampicillin-sulbactam | ≤0.06-0.125 | ≤0.06 | ≤0.06 | |||||
Doxycycline | ≤0.06-0.25 | 0.125 | 0.25 | |||||
Peptostreptococcus spp. (23)n | ||||||||
BMS-284756 | 0.03-0.25 | 0.06 | 0.25 | |||||
Moxifloxacin | 0.06-2 | 0.25 | 0.5 | |||||
Levofloxacin | 0.25->8 | 0.5 | 4 | |||||
Ciprofloxacin | 0.25->8 | 0.5 | 2 | |||||
Amoxicillin-clavulanate | ≤0.06-2 | 0.125 | 1 | |||||
Cefotetan | ≤0.06-8 | 1 | 4 | |||||
Penicillin G | ≤0.015-2 | 0.06 | 0.25 | |||||
Ampicillin-sulbactam | ≤0.06-2 | 0.25 | 0.5 | |||||
Doxycycline | ≤0.06->32 | 0.5 | 32 | |||||
Porphyromonas macacae (10) | ||||||||
BMS-284756 | 0.03-0.06 | 0.06 | 0.06 | |||||
Moxifloxacin | 0.03-0.125 | 0.125 | 0.125 | |||||
Levofloxacin | 0.125-0.5 | 0.25 | 0.25 | |||||
Ciprofloxacin | 0.5-1 | 0.5 | 1 | |||||
Amoxicillin-clavulanate | ≤0.06-0.125 | ≤0.06 | ≤0.06 | |||||
Cefotetan | 0.25-1 | 0.5 | 1 | |||||
Penicillin G | 0.03-1 | 0.5 | 1 | |||||
Ampicillin-sulbactam | ≤0.06-0.125 | ≤0.06 | ≤0.06 | |||||
Doxycycline | 0.125-16 | 0.125 | 0.25 | |||||
Porphyromonas spp. (12)o | ||||||||
BMS-284756 | 0.03-0.06 | 0.03 | 0.06 | |||||
Moxifloxacin | 0.03-0.125 | 0.06 | 0.125 | |||||
Levofloxacin | 0.125-0.5 | 0.125 | 0.5 | |||||
Ciprofloxacin | 0.5-2 | 0.5 | 1 | |||||
Amoxicillin-clavulanate | ≤0.06-≤0.06 | ≤0.06 | ≤0.06 | |||||
Cefotetan | ≤0.06-0.25 | 0.125 | 0.25 | |||||
Penicillin G | ≤0.015-1 | ≤0.015 | ≤0.015 | |||||
Ampicillin-sulbactam | ≤0.06-≤0.06 | ≤0.06 | ≤0.06 | |||||
Doxycycline | 0.125-0.25 | 0.125 | 0.25 | |||||
Prevotella heparinolytica (10) | ||||||||
BMS-284756 | 0.06-0.25 | 0.125 | 0.25 | |||||
Moxifloxacin | 0.125-0.25 | 0.125 | 0.25 | |||||
Levofloxacin | 0.5-1 | 0.5 | 0.5 | |||||
Ciprofloxacin | 2-4 | 2 | 4 | |||||
Amoxicillin-clavulanate | 0.125-0.25 | 0.25 | 0.25 | |||||
Cefotetan | 1-2 | 1 | 2 | |||||
Penicillin G | 0.125-0.25 | 0.125 | 0.25 | |||||
Ampicillin-sulbactam | 0.25-0.5 | 0.25 | 0.5 | |||||
Doxycycline | 0.125-4 | 0.125 | 4 | |||||
Prevotella spp., pigmented (17)p | ||||||||
BMS-284756 | 0.06-0.25 | 0.125 | 0.25 | |||||
Moxifloxacin | 0.06-0.5 | 0.25 | 0.5 | |||||
Levofloxacin | 0.25-1 | 0.25 | 1 | |||||
Ciprofloxacin | 0.25-2 | 0.5 | 2 | |||||
Amoxicillin-clavulanate | ≤0.06-0.25 | ≤0.06 | 0.25 | |||||
Cefotetan | ≤0.06-8 | 1 | 4 | |||||
Penicillin G | ≤0.015-16 | 0.5 | 8M/PICK>{tt} | |||||
Ampicillin-sulbactam | ≤0.06-0.5 | 0.125 | 0.5 | |||||
Doxycycline | ≤0.06-8 | 0.25 | 2 | |||||
Prevotella spp., non pigmented (15)q | ||||||||
BMS-284756 | 0.06-0.25 | 0.125 | 0.25 | |||||
Moxifloxacin | 0.06-0.5 | 0.25 | 0.5 | |||||
Levofloxacin | 0.25-1 | 0.5 | 1 | |||||
Ciprofloxacin | 0.5-2 | 1 | 2 | |||||
Amoxicillin-clavulanate | ≤0.06-1 | ≤0.06 | 1 | |||||
Cefotetan | 0.5-32 | 2 | 16 | |||||
Penicillin G | ≤0.015-16 | 0.5 | 8 | |||||
Ampicillin-sulbactam | ≤0.06-2 | 0.125 | 1 | |||||
Doxycycline | ≤0.06-8 | 0.25 | 8 | |||||
Veillonella spp. (11) | ||||||||
BMS-284756 | 0.125-4 | 0.25 | 0.5 | |||||
Moxifloxacin | 0.125-2 | 0.25 | 0.5 | |||||
Levofloxacin | 0.25-4 | 0.25 | 0.5 | |||||
Ciprofloxacin | 0.125-4 | 0.125 | 0.25 | |||||
Amoxicillin-clavulanate | ≤0.06-2 | 0.125 | 0.5 | |||||
Cefotetan | 0.5-4 | 1 | 2 | |||||
Penicillin G | 0.125-4 | 0.25 | 4 | |||||
Ampicillin-sulbactam | 0.125-2 | 0.25 | 1 | |||||
Doxycycline | 1-16 | 1 | 2 | |||||
Gram-positive Bacillus spp. (11)r | ||||||||
BMS-284756 | 0.06-2 | 0.125 | 1 | |||||
Moxifloxacin | 0.125-2 | 0.5 | 1 | |||||
Levofloxacin | 0.25-4 | 1 | 2 | |||||
Ciprofloxacin | 0.25-8 | 1 | 4 | |||||
Amoxicillin-clavulanate | ≤0.06-0.5 | ≤0.06 | 0.125 | |||||
Cefotetan | ≤0.06-8 | 1 | 4 | |||||
Penicillin G | ≤0.015-0.25 | 0.03 | 0.125 | |||||
Ampicillin-sulbactam | ≤0.06-1 | ≤0.06 | 0.125 | |||||
Doxycycline | 0.125-1 | 0.5 | 0.5 |
Corynebacterium accolens (n = 1), C. amycolatum (n = 1), “C. aquaticum” (n = 10), C. argentoratense (n = 1), C. jeikeium (n = 1), C. minutissimum (n = 3), C. propinquum (n = 1), and C. ulcerans (n = 1).
Centers for Disease Control and Prevention (CDC) groups EF-4a (n = 4) and EF-4b (n = 11).
Enterococcus avium (n = 2), E. durans (n = 5), E. faecalis (n = 6), and E. malodoratus (n = 1).
Actinobacillus actinomycetemcomitans (n = 1) and Actinobacillus sp. (n = 1); Capnocytophaga canimorsus (n = 3), C. gingivalis (n = 1), and Capnocytophaga spp. (n = 2); Haemophilus aphrophilus (n = 1), H. influenzae (n = 1), and H. parainfluenzae (n = 5); and Weeksella virosa (n = 1).
Moraxella atlantae (n = 3), M. bovis (n = 1), M. catarrhalis (n = 10), M. lacunata (n = 2), M. nonliquefaciens (n = 3), and M. osloensis (n = 2).
Neisseria cinerea-N. flavescens group (n = 1), N. elongata subsp. elongata (n = 2), N. elongata subsp. nitroreducens(n = 2), N. subflava (n = 4), N. weaveri (n = 10), and an unidentifiable Neisseria sp. (n = 1).
Pasteurella canis (n = 9) and P. dagmatis (n = 6).
Staphylococcus hominis (n = 2), S. hyicus (n = 2), S. intermedius (n = 6), S. saprophyticus (n = 1), S. sciuri subsp. lentus(n = 1), and S. warneri (n = 7).
Streptococcus anginosus (n = 7), S. constellatus (n = 6), and S. intermedius (n = 6).
Bacteroides ureolyticus (n = 3), Campylobacter gracilis (n = 5), C. mucosalis (n = 2), and C. rectus (n = 3).
Eubacterium aerofaciens (n = 1), E. lentum (n = 1), E. saburreum (n = 3), E. yurii subsp. yurrii (n = 2), and organisms with no good fit (n = 6).
Fusobacterium nucleatum (n = 10), F. nucleatum subsp. animalis (n = 1), and F. necrophorum (n = 1).
Fusobacterium necrophorum (n = 3) and F. nucleatum (n = 11).
Peptostreptococcus anaerobius (n = 7), P. asaccharolyticus (n = 1), P. ivorii (n = 1), P. magnus (n = 3), P. micros (n = 8), P. prevotii (n = 2), and P. tetradius (n = 1).
Porphyromonas cangingivalis (n = 4) and P. gingivalis (n = 8).
Prevotella denticola (n = 2), P. intermedia-P. nigrescens group (n = 7), P. melaninogenica (n = 4), P. pallens (n = 3), and P. tannerae (n = 1).
Prevotella buccae (n = 7), P. buccalis (n = 1), P. disiens (n = 1), P. oris (n = 5), and an organism with no good fit (n = 1).
Actinomyces israelii (n = 1), A. meyeri (n = 1), A. naeslundii (n = 2), and A. viscosus (n = 2); Lactobacillus catenaformis (n = 1), L. lactis (n = 1), L. plantarum (n = 2), and a Lactobacillus species with no good fit (n = 1).
50% and 90%, MIC50 and MIC90, respectively; NA, not applicable.